Actively Recruiting
Randomized Trial Comparing Oral Itraconazole Plus Standard Care to Standard Care Alone for Non-Cystic Fibrosis Bronchiectasis with Chronic Aspergillus Infection
Led by Post Graduate Institute of Medical Education and Research, Chandigarh · Updated on 2026-10-26
80
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to study non-cystic fibrosis bronchiectasis, a chronic lung disease characterized by permanent widening of the airways leading to symptoms like chronic cough and breathlessness. The study focuses on the role of fungal infection, particularly Aspergillus fumigatus, which is linked to worsening lung function and increased exacerbation risk. Researchers will evaluate if treating chronic Aspergillus infection can reduce bronchiectasis flare-ups in patients without cystic fibrosis or allergic bronchopulmonary aspergillosis ABPA. Participants will be randomly assigned to one of two groups one receiving standard care alone and the other receiving oral itraconazole capsules 65 mg twice daily for six months in addition to standard care. The study will last for 12 months, with six months of treatment followed by six months of observation. The itraconazole treatment aims to reduce fungal burden in the airways, potentially lowering the risk of future bronchiectasis exacerbations. During the study, participants will be monitored regularly to assess the frequency of bronchiectasis exacerbations, lung function through spirometry, exercise capacity via a six-minute walk test, quality of life using a health questionnaire, and any side effects of treatment. Researchers will also track the time to first exacerbation and adverse events throughout the 12-month period. This comprehensive follow-up will help determine the impact of itraconazole on disease progression and patient well-being.
CONDITIONS
Brief Title
Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here